CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy And Safety of BXCL501 Evaluated For At-Home Use In A Multisite Double-Blind Placebo-Controlled Trial For Agitation Associated With Schizophrenia And Bipolar Disorder

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05658510
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:17.434901+00:00
Published At: 2025-09-18T00:00:00+00:00
Record Updated At: 2025-09-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Agitation,Psychomotor", "Bipolar I Disorder", "Bipolar II Disorder", "Schizophrenia", "Schizoaffective Disorder", "Schizophreniform Disorders"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-09-18"
protocolSection.identificationModule.nctId: "NCT05658510"
protocolSection.identificationModule.officialTitle: "Efficacy And Safety of BXCL501 Evaluated For At-Home Use In A Multisite Double-Blind Placebo-Controlled Trial For Agitation Associated With Schizophrenia And Bipolar Disorder"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.